Literature DB >> 24534544

Incorporating patient-reported outcomes into hepatitis C virus treatment studies.

Donna M Evon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24534544      PMCID： PMC4104216          DOI： 10.1016/j.cgh.2014.02.017

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  13 in total

1.  Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Authors:  Stephanie R Land; D Lawrence Wickerham; Joseph P Costantino; Marcie W Ritter; Victor G Vogel; Myoungkeun Lee; Eduardo R Pajon; James L Wade; Shaker Dakhil; James B Lockhart; Norman Wolmark; Patricia A Ganz
Journal:  JAMA       Date:  2006-06-05       Impact factor: 56.272

2.  HCV treatment--no more room for interferonologists?

Authors:  Joost P H Drenth
Journal:  N Engl J Med       Date:  2013-04-23       Impact factor: 91.245

3.  Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C.

Authors:  Zobair M Younossi; Maria Stepanova; Linda Henry; Edward Gane; Ira M Jacobson; Eric Lawitz; David Nelson; Lynn Gerber; Fatema Nader; Sharon Hunt
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-06       Impact factor: 11.382

Review 4.  Patient-reported outcomes assessment in cancer trials: taking stock, moving forward.

Authors:  Joseph Lipscomb; Bryce B Reeve; Steven B Clauser; Jeffrey S Abrams; Deborah Watkins Bruner; Laurie B Burke; Andrea M Denicoff; Patricia A Ganz; Kathleen Gondek; Lori M Minasian; Ann M O'Mara; Dennis A Revicki; Edwin P Rock; Julia H Rowland; Maria Sgambati; Edward L Trimble
Journal:  J Clin Oncol       Date:  2007-11-10       Impact factor: 44.544

Review 5.  Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology.

Authors:  Ethan Basch; Amy P Abernethy; C Daniel Mullins; Bryce B Reeve; Mary Lou Smith; Stephen Joel Coons; Jeff Sloan; Keith Wenzel; Cynthia Chauhan; Wayland Eppard; Elizabeth S Frank; Joseph Lipscomb; Stephen A Raymond; Merianne Spencer; Sean Tunis
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

6.  Sofosbuvir for previously untreated chronic hepatitis C infection.

Authors:  Eric Lawitz; Alessandra Mangia; David Wyles; Maribel Rodriguez-Torres; Tarek Hassanein; Stuart C Gordon; Michael Schultz; Mitchell N Davis; Zeid Kayali; K Rajender Reddy; Ira M Jacobson; Kris V Kowdley; Lisa Nyberg; G Mani Subramanian; Robert H Hyland; Sarah Arterburn; Deyuan Jiang; John McNally; Diana Brainard; William T Symonds; John G McHutchison; Aasim M Sheikh; Zobair Younossi; Edward J Gane
Journal:  N Engl J Med       Date:  2013-04-23       Impact factor: 91.245

7.  Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.

Authors:  Ira M Jacobson; Stuart C Gordon; Kris V Kowdley; Eric M Yoshida; Maribel Rodriguez-Torres; Mark S Sulkowski; Mitchell L Shiffman; Eric Lawitz; Gregory Everson; Michael Bennett; Eugene Schiff; M Tarek Al-Assi; G Mani Subramanian; Di An; Ming Lin; John McNally; Diana Brainard; William T Symonds; John G McHutchison; Keyur Patel; Jordan Feld; Stephen Pianko; David R Nelson
Journal:  N Engl J Med       Date:  2013-04-23       Impact factor: 91.245

8.  The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.

Authors:  Sara Ahmed; Richard A Berzon; Dennis A Revicki; William R Lenderking; Carol M Moinpour; Ethan Basch; Bryce B Reeve; Albert W Wu
Journal:  Med Care       Date:  2012-12       Impact factor: 2.983

Review 9.  Review of patient-reported outcome measures in chronic hepatitis C.

Authors:  Leah Kleinman; Sally Mannix; Yong Yuan; Shannon Kummer; Gilbert L'Italien; Dennis Revicki
Journal:  Health Qual Life Outcomes       Date:  2012-08-07       Impact factor: 3.186

10.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186
View more
  2 in total

1.  Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C.

Authors:  Donna M Evon; Carol E Golin; Rachel Ruffin; Shauna Ayres; Michael W Fried
Journal:  Pilot Feasibility Stud       Date:  2018-06-27

2.  Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir.

Authors:  Xinyi Ng; Chizoba Nwankwo; Jean Marie Arduino; Shelby Corman; Kathryn Eilene Lasch; Jacqueline Mary Lustrino; Sushma Patel; Heather Loryn Platt; Jingjun Qiu; Jan Sperl
Journal:  Patient Prefer Adherence       Date:  2018-12-11       Impact factor: 2.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.